Although our dataset is too small to carry out survival analysis, an association between increased SULF2 and poor outcome has been shown in other studies including a 13% increase in hazard ratio in esophageal cancer [8] and in multiple myeloma where SULF2 gene expression was shown to be an indicator of progression and poor prognosis [34]. This evidence concerns the gene SULF2 and AL amyloidosis.